INTRODUCTION

THE MAINTENANCE OF WAKEFULNESS TEST (MWT) WAS FIRST INTRODUCED AS A VARIANT OF THE MULTIPLE SLEEP LATENCY TEST, AND ITS USE AS A CLINICAL AND RESEARCH TOOL HAS GROWN CONSID-ERABLY IN RECENT YEARS.
The MWT protocol is similar to that of the Multiple Sleep Latency Test; however, subjects are required to stay awake without using any excessive mental or physical methods while sitting upright in a darkened room. Originally, the MWT used 4 evenly spaced 20-minute trials. 1 In subsequent investigation of patients with obstructive sleep apnea (OSA), the MWT trials were lengthened to 40 minutes to try to eliminate the observed ceiling effect. 2 Both trial lengths are currently used, the particular length depending on the subjects' degree of clinically reported sleepiness.
Most research has focused on MWT scores in patients with OSA 3 and narcolepsy. 4 The effects of treatment on MWT mean sleep latency is also an area of increased research. 5 While the MWT is used increasingly in clinical settings, there is a relative lack of normative data. Only 1 published study has comprehensively examined MWT mean sleep latency in 64 normal subjects. 6 The authors suggest that an abnormal MWT result (< 2 SD from the mean) is a mean sleep latency less than 19.4 minutes in a 40-minute trial and less than 10.9 minutes in a 20-minute trial. 6 A drawback of this study was the way in which the subjects were recruited. They were primarily advertisement respondents and hospital employees. While the subjects were carefully screened for good health, a potential sampling bias exists. They may have volunteered to participate due to a concern about daytime sleepiness or a sleep disorder. The aim of this study was to add to the existing normative data on the MWT sleep latency by randomly selecting healthy subjects from the general community, naïve to the objective of the study.
METHODS
This study was approved by the relevant research and ethics committees at the Repatriation General Hospital -Daw Park, Adelaide, and Austin Health, Melbourne. All subjects gave written informed consent.
Participants
Forty-one subjects were recruited (17 at Austin Health, Melbourne, and 24 at the Repatriation General Hospital -Daw Park, Adelaide) to serve as a control group for a trial investigating the effects of mild to moderate OSA on neurocognitive function and the relative treatment effects of continuous positive airway pressure and a mandibular-advancement splint in the group with OSA.
Subjects were recruited using a computer program to randomly select telephone numbers from the telephone book, within a 30-km radius of each hospital. An assistant then called these numbers and, using a set script, invited subjects to participate in the trial. This script was specifically designed for the study and consisted of a brief introduction and then a general health screen.
In the introduction, the assistant began by explaining that the study was examining the relationship between cardiovascular The mean results are consistent with previously published normative data. However, the SDs found in this study are smaller, and, thus, the lower normal limit suggested here is 4 to 6 minutes longer. The subjects in this study were randomly selected from the general population and may, therefore, be a truer representation of the normal population than in the previous study in which subjects were recruited via hospital advertisements and word of mouth.
measures, memory, IQ, and problem solving (these were all measures taken in examination of the effectiveness of treatment for the patients with mild to moderate OSA). No mention was made that the study was investigating sleep, sleep apnea, or daytime sleepiness. It was explained that participants would need to come to the hospital for 1.5 days and 1 overnight stay. It was also explained that the benefit for participating in this study was a comprehensive health check but no remuneration. Potential subjects then answered a general screen for health complaints (respiratory, cardiovascular, and psychiatric disorders) and sleep difficulties (snoring). Volunteers were excluded from the study if they were not between the ages of 30 and 70 years; if English was not their first language; if they were heard to snore more than 1 night per week; if they were on any medications for respiratory, cardiovascular, or psychiatric disorders; or if they had a history of drug or alcohol abuse.
Procedure Overnight Polysomnography
Subjects were required to keep a sleep diary for a week prior to the testing and to maintain their typical sleep-wake routine for that week. They arrived at the laboratory between 8 PM and 9 PM on the night of testing. Height and weight were measured to calculate body mass index. Both centers used the same equipment and settings to acquire the data. Polysomnography (PSG) (Sleepwatch Compumedics, Melbourne, Australia) included C 3 /A 2 and C 4 /A 1 electroencephalograms, electrooculogram, submental electromyogram, electrocardiogram, airflow, respiratory effort, and SaO 2 . The PSGs and MWTs were manually analyzed in 30-second epochs according to standard criteria, 7 and the electroencephalogram arousals were scored using American Sleep Disorders Association guidelines. 8 Sleep-disordered breathing was defined according the following criteria: an apnea was defined as a > 80% reduction in airflow lasting at least 10 seconds and was classified as obstructive, central, or mixed depending on whether or not there were ongoing respiratory efforts. A hypopnea was defined as an event of at least 10 seconds duration with a > 50% reduction from baseline in at least 2 of the following 3 signals: airflow, thoracic movement, and abdominal movement. The apnea-hypopnea index (AHI) was calculated by dividing the number of apneas plus hyponeas by the hours of sleep.
MWT Protocol
On the day after the PSG, subjects underwent four 40-minute MWT trials at 2-hourly intervals, with the first beginning between 8 AM and 10 AM. Smoking was prohibited during the 30 minutes before a trial. Subjects were required to abstain from consuming caffeinated beverages during the test day. Subjects also gave a urine sample on the day of testing, which was screened for habitual drugs of abuse. All subjects had negative results. Breakfast (cereal, milk, and toast) was served at least 1 hour before the first MWT trial, and lunch (sandwich or roll, piece of fruit, and noncaffeinated beverage) immediately after the second trial (approximately 12 noon), 1 hour before the next trial. All trials were performed in a similar setting using a simplified recording montage (C 3 /A 2 , O 1 /A 2 , electromyogram, and electrooculogram). Bedrooms were sound attenuated, insulated from external light, and equipped with overhead dimmer lights.
Ambient temperature in the room was approximately 22 o C. Bedroom doors were closed, and all monitoring was performed external to the bedroom to keep noise to a minimum. During each MWT trial, subjects sat semi-upright (10 o to 30 o back from vertical) in a comfortable lounge chair, which had a high back to support the head and neck. Prior to each trial, subjects were instructed to "keep your eyes open and try not to fall asleep." Subjects were asked not to use any extraordinary mental or physical measures (eg, face slapping) to avoid sleep. The recordings were then started, and the lights dimmed to an illumination of 1 lux. Each trial was terminated at the first occurrence of sustained sleep (3 consecutive 30-second epochs of stage 1 sleep or 1 epoch of any other stage) or after 40 minutes if there was no sleep. The 4 sleep latencies were then averaged over the day to obtain the mean MWT sleep latency.
Data Analysis
In order to compare our data with previously published normative data, we analyzed the data using the same 4 sleep-onset criteria. Sleep latency was calculated separately for the first 20 minutes of recording and for the whole 40-minute recording period. All MWT trials for each subject were analyzed according to these 4 protocols by 1 trained technician at the Adelaide laboratory.
For the 20-minute period-Sleep onset was defined as (1) the first appearance of a 10-second burst of theta or the first epoch of sleep (MICROMWT20) and (2) 
RESULTS
Ten subjects were found to have an AHI of more than 10 per hour, and data from these subjects were excluded from further analysis because of the concern that subclinical OSA may affect sleep latency. This resulted in a final sample of 31 subjects, 8 women and 23 men (age 48.7 years ± 9.7 SD). Their demographic, subjective sleepiness, and PSG variables are presented in Table 1 . MWT mean sleep-latency results for all 4 scoring criteria are presented in Table 2 .
The previous study of normative MWT data 6 used a statistical criterion of 2 SDs below the mean as the cut-off point for normalcy, as suggested by the American Electroencephalographic Society. 9 Using this criterion, the cut-off points from the current data for normal mean sleep latency for all scoring criteria were 14.0 minutes (MICROMWT20), 15.2 minutes (MWT20), 16.1 minutes (MICROMWT40), and 25.5 minutes (MWT40). The previous authors' reported mean sleep latencies, in minutes, were 18.1 ± 3.6, 18.7 ± 2.6, 32.6 ± 9.9 and 35.2 ± 7.9, respectively, and their suggested cut-offs for normalcy, in minutes, were 10.9, 13.5, 12.9 and 19.4, respectively. 6 
DISCUSSION
The range of normal scores found in this study is very similar to that previously found by Doghramji et al. 6 In particular, the mean sleep latencies for both trial protocols are virtually identical. However the SD of scores in this study is smaller and resulted in higher cut-off points for abnormality. The subjects in this study were randomly selected from the telephone book in a 30-km radius around the hospitals in Adelaide and Melbourne and were invited to participate via a phone call. The previous study used volunteers responding to advertisements or word of mouth between hospital employees. It is possible that some subjects who volunteered may have selected themselves because they had some daytime sleepiness or were concerned about a possible sleep disorder. Because the current study recruited the subjects without specific mention of daytime sleepiness or sleep disorders, potential sample bias was avoided.
The subjects in the current study were required to sit upright in a lounge chair rather than upright in bed, as occurred in the previous study. Some subjects may have been more inclined to fall asleep while sitting in a bed because of the contextual cue to sleep in this environment. Also, the illumination level during the MWT trials in the previous study was much lower (0.10-0.13 lux compared to 1 lux in this study). We believe that if the MWT is to be generalizable to real-life situations, then the conditions of the test need to be comparable. These differences in the study protocol and recruitment methods may have been enough to increase the variance of sleep-latency scores in the Doghramji et al study 6 and, therefore, reduce the lower normal limit suggested by the authors.
Additionally, the different results in our study compared to Doghramji et al's 6 are unlikely to be explained by different exclusion criteria for OSA. The previous authors used a slightly more stringent AHI cut off (ie, AHI > 5 for 30-to 39-year-olds and AHI > 10 for 60-to 69-year-olds) than in this study (AHI > 10 for all subjects). This exclusion criterion may be expected to result in the selection of fewer subjects with sleepiness and, therefore, a narrower SD for MWT sleep latency. In fact, the findings in the 2 studies were opposite, suggesting that the different exclusion criteria did not affect the resulting spread of mean sleep-latency scores. In summary, this study extends the base of normative data for the MWT. The results for mean sleep latency, in our Australian population, are remarkably similar to those obtained from 6 North American and 1 South African center years earlier.
However, the present results, which were obtained in a randomly selected sample of the normal healthy population, suggest that the lower limit for normal sleep latency may be higher than previously reported. This study illustrates the need for further investigation of these cut-off points and, perhaps, the introduction of a grey area similar to that in current usage for the Multiple Sleep Latency Test.
